HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ranjit Ray Selected Research

Protein Kinases (Protein Kinase)

1/2020Hepatitis C Virus Mediated Inhibition of miR-181c Activates ATM Signaling and Promotes Hepatocyte Growth.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ranjit Ray Research Topics

Disease

46Infections
01/2022 - 03/2002
15Hepatocellular Carcinoma (Hepatoma)
01/2021 - 10/2003
9Neoplasms (Cancer)
11/2021 - 11/2015
8Fibrosis (Cirrhosis)
01/2019 - 03/2005
8Vesicular Stomatitis
10/2011 - 04/2002
7Liver Diseases (Liver Disease)
01/2019 - 06/2006
6Liver Cirrhosis (Hepatic Cirrhosis)
01/2019 - 03/2005
5Virus Diseases (Viral Diseases)
07/2014 - 07/2002
4Hepatitis C
01/2020 - 03/2005
4Persistent Infection
01/2014 - 03/2008
3COVID-19
01/2022 - 12/2020
3Inflammation (Inflammations)
01/2022 - 11/2013
3Chronic Hepatitis C
01/2021 - 03/2005
3Insulin Resistance
02/2014 - 03/2008
2Liver Neoplasms (Liver Cancer)
01/2020 - 11/2017
2Neoplasm Metastasis (Metastasis)
01/2020 - 11/2017
2Disease Progression
03/2015 - 06/2005
1Vaccinia
01/2022
1Alcoholic Fatty Liver
01/2021
1Obesity
01/2021
1Ataxia Telangiectasia (Louis Bar Syndrome)
01/2020
1Viremia
01/2019
1End Stage Liver Disease
03/2015

Drug/Important Bio-Agent (IBA)

25Proteins (Proteins, Gene)FDA Link
01/2021 - 07/2002
9Glycoproteins (Glycoprotein)IBA
07/2013 - 03/2002
8Neutralizing AntibodiesIBA
01/2022 - 03/2002
8Antiviral Agents (Antivirals)IBA
01/2019 - 03/2005
7Messenger RNA (mRNA)IBA
01/2022 - 05/2011
7Complement System Proteins (Complement)IBA
01/2019 - 03/2002
7InterferonsIBA
03/2015 - 03/2005
6VaccinesIBA
01/2022 - 03/2008
6CytokinesIBA
03/2021 - 05/2010
4LigandsIBA
03/2021 - 03/2014
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2021 - 05/2006
4RNA (Ribonucleic Acid)IBA
01/2020 - 10/2003
3CCAAT-Enhancer-Binding ProteinsIBA
10/2021 - 07/2014
3Transcription Factors (Transcription Factor)IBA
10/2021 - 03/2014
3Transforming Growth Factors (Transforming Growth Factor)IBA
01/2019 - 01/2017
3GelsolinIBA
04/2018 - 01/2012
3MicroRNAs (MicroRNA)IBA
03/2015 - 01/2014
3Poly I-CIBA
01/2014 - 11/2007
3Viral ProteinsIBA
09/2012 - 06/2010
3AntibodiesIBA
10/2011 - 03/2002
2AntigensIBA
01/2022 - 04/2008
2InflammasomesIBA
01/2022 - 01/2017
2Interleukin-6 (Interleukin 6)IBA
03/2021 - 05/2010
2ChemokinesIBA
03/2021 - 01/2017
2Fibrinogen (Factor I)FDA Link
03/2021 - 05/2010
2Cyclin D1IBA
01/2020 - 11/2017
2CollagenIBA
01/2020 - 01/2017
2Indicators and Reagents (Reagents)IBA
01/2019 - 04/2014
2LipidsIBA
01/2019 - 04/2014
2Matrix Metalloproteinase 2 (Gelatinase A)IBA
12/2017 - 01/2017
2Conditioned Culture MediaIBA
12/2017 - 01/2016
2Insulin Receptor Substrate ProteinsIBA
02/2014 - 03/2008
2Insulin (Novolin)FDA Link
02/2014 - 06/2010
2Apolipoproteins E (ApoE)IBA
10/2011 - 12/2003
2Interferon-betaIBA
11/2010 - 11/2007
2GlycosaminoglycansIBA
04/2007 - 05/2004
2Ribavirin (Virazole)FDA LinkGeneric
01/2007 - 04/2006
1Pharmaceutical PreparationsIBA
01/2022
1Lipid NanoparticlesIBA
01/2022
1NucleosidesIBA
01/2022
1(5- (2,4- bis((3S)- 3- methylmorpholin- 4- yl)pyrido(2,3- d)pyrimidin- 7- yl)- 2- methoxyphenyl)methanolIBA
11/2021
1capivasertibIBA
11/2021
1Mechanistic Target of Rapamycin Complex 1IBA
11/2021
1ChromatinIBA
10/2021
1SARS-CoV-2 spike proteinIBA
10/2021
1Long Noncoding RNAIBA
10/2021
1TenascinIBA
03/2021
1Protein Isoforms (Isoforms)IBA
01/2021
1SmokeIBA
01/2021
1Neoplasm Antigens (Tumor Antigens)IBA
01/2021
1AngiotensinsIBA
12/2020
1GlypicansIBA
01/2020
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2020
1CateninsIBA
01/2020
1Human Serum AlbuminFDA LinkGeneric
01/2020
1Protein Kinases (Protein Kinase)IBA
01/2020
1Imatinib Mesylate (Gleevec)FDA Link
01/2020
1Ataxia Telangiectasia Mutated ProteinsIBA
01/2020
1Alkaline PhosphataseIBA
01/2019
1Rheumatoid FactorIBA
01/2019
1Complement Membrane Attack Complex (Membrane Attack Complex)IBA
01/2019
1AlbuminsIBA
01/2019
1Transforming Growth Factor beta (TGF-beta)IBA
12/2017
1EndoglinIBA
11/2017
1InterleukinsIBA
01/2017
1Cysteine (L-Cysteine)FDA Link
01/2017
1Membrane Proteins (Integral Membrane Proteins)IBA
01/2016
1Complement C3-C5 Convertases (C3 Convertase)IBA
01/2016
1Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA
11/2015
1ErbB Receptors (EGF Receptor)IBA
03/2015
1Epidermal Growth Factor (EGF)IBA
03/2015
1Claudin-1IBA
03/2015
1Biomarkers (Surrogate Marker)IBA
03/2015

Therapy/Procedure

9Therapeutics
01/2022 - 04/2006
2Liver Transplantation
03/2015 - 02/2014
1Intraperitoneal Injections
01/2021
1Aftercare (After-Treatment)
01/2019